In colon carcinomas, receptor mutations are rare (Jang et al, 2000), but aberrant splicing causes a decrease in functional FGFR3-IIIb, accompanied by a switch to FGFR1-IIIc (Jang, 2005). This evidence concerns the gene FGFR3 and colon carcinoma.